Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Pay close attention to earnings reports, and you'll usually find a few surprises.

5 Surprising Numbers From Cronos' Q4 Earnings Report

Aurora Cannabis

Canopy Growth

Tilray Brands

Cannabis growers and distributors dropped for a second straight week, falling with the broader market and on increased concerns about partisan sniping.

Cannabis stocks slump for second straight week as prospects dim for nationwide legalization

HEXO Corp

OrganiGram Holdings Inc.

SNDL Inc.

Marijuana stocks have been up and down for several years and still seek firm footing. Right now, these seven aren't worth your money.

7 Marijuana Stocks That Look Way Too Expensive Here

Marijuana will provide the basis for many of tomorrow's blockbuster drugs. David Borun shows you how to invest in this burgeoning industry.

Investors: The Marijuana Boom Is Now

Investors are unlikely to see green if they buy these poor-performing cannabis stocks.

3 Pot Stocks to Avoid Like the Plague in March

The company's mixed quarter saw it trounce revenue estimates, but fall short of profitability forecasts.

Cronos Group Slides on Q4 Results

Amyris

Aphria

GrowGeneration Corp

Village Farms International

These are the marijuana stocks on the NASDAQ with the best value, fastest growth, and the most momentum for March.

Top Marijuana Stocks on the NASDAQ for March 2021

Cronos Group Inc. shares slid 2.4% Friday, after the Canadian cannabis company posted a wider-than-expected loss for the fourth quarter, but revenue that beat estimates, buoyed by growth in the Canadian adult-use market and U.S.

Cannabis Watch: Cronos stock falls after wider-than-expected loss, but revenue is boosted by Canadian adult-use cannabis market

Cronos Group Inc. (CRON) CEO Kurt Schmidt on Q4 2020 Results - Earnings Call Transcript

Cronos Group re ported a far bigger Q4 loss than expected and warned that low weed prices could continue to weigh on the company. The post Marijuana Stocks Fall On Cronos Group's Steep Loss, Price Warning appeared first on Investor's Business Daily.

Marijuana Stocks Fall On Cronos Group's Steep Loss, Price Warning

Cronos Group reported a net loss of $111.7 million during its fourth quarter. But the Canadian cannabis firm is still sitting on a lot of cash.

Pot Stock Cronos Is Slipping. Its Loss Was Wider Than Expected.

Cronos Group Inc. shares slid 3% in premarket trade Friday, after the Canadian cannabis company posted a wider-than-expected loss for the fourth quarter, but revenue that beat estimates. The Toronto-based company swung to a net loss of $111.7 million, or 31 cents a share, in the quarter, after income of $61.6 million, or 17 cents a share, in the year-earlier period.

Canadian cannabis company Cronos posts wider-than-expected Q4 loss but revenue beats estimates

The cannabis sector has yet to completely shed its reputation of being part of the "wild, wild west," but much has changed, T3 Ventures President Tahira Rehmatullah said Thursday during Benzinga's virtual Cannabis Capital Conference.  Cannabis operators with plenty of experience have likely at some point entered into a deal where there was no model or the depth that was needed, Rehmatullah said.

Why The Stigma Around Cannabis Investments Is 'Gone'

Airbnb

Cinemark Holdings

Salesforce

DraftKings

Fisker Inc

Nikola

The Nasdaq Composite index traded down Wednesday morning, hurt most by Apple, which traded down about 1.6%, with Constellation Pharmaceuticals the biggest loser with a 16.8% pullback.

Earnings Previews: Airbnb, Fisker, Nikola, Salesforce, Cinemark, Cronos and DraftKings

GameStop

The bubble pop is moving quickly from sector to sector as marijuana stocks took center stage in one of the biggest and quickest to rise and fall recently. The post 7 Marijuana Stocks That Could Still Go Down in Flames appeared first on InvestorPlace.

7 Marijuana Stocks That Could Still Go Down in Flames

The AdvisorShares Pure US Cannabis ETF has surpassed $1 billion in assets under management, according to a company statement released Tuesday. The ETF, which trades under the ticker MSOS, launched on September 2, 2020 and has grown from $2.5 million in assets to now $1 billion in just six months. The fund has returned 110% since its inception and 37% in 2021 alone. The AdvisorShares ETF was the first US exchange traded fund to focus solely on American cannabis companies and multi-state operations (MSOs), or companies directly involved in the legal production and distribution of cannabis.  The fund's inflows are a sign of growing investor interest in the cannabis space amid speculation that the Biden administration will keep its campaign promises and decriminalize marijuana. Some Democrats in Congress have pushed even further, advocating for the full legalization of cannabis in the US.

The first US cannabis ETF surpassed $1 billion in AUM in its first 6 months of trading

Curaleaf Holdings, Inc.

CRON stock stands to gain from state-level cannabis legalization as well as from speculation around federal legalization. The post Cronos Group and Other Cannabis Stocks Could See Higher Highs appeared first on InvestorPlace.

Cronos Group and Other Cannabis Stocks Could See Higher Highs

Constellation Brands

Trulieve Cannabis Corp.

These five marijuana stocks are for careful, conservative investors. They each have safe financial traits for those who like to play it safe.

5 Marijuana Stocks for the Conservative Investor

Green Thumb Industries Inc.

Innovative Industrial Properties

Jazz Pharmaceuticals

With many people seeking natural therapies to address pandemic-related stress, the backdrop is favorable for marijuana stocks. The post 8 Medical Marijuana Stocks That Are Just What the Doctor Ordered appeared first on InvestorPlace.

8 Medical Marijuana Stocks That Are Just What the Doctor Ordered

The ETFMG Alternative Harvest ETF (NYSE: MJ) traded lower on Monday as investors continued to take profits on the post-election run-up in cannabis stocks. This week is a big week in the cannabis space with several potential catalysts of note ahead.

4 Things Cannabis Investors Should Watch This Week

Investors will focus on regular top and bottom-line numbers along with its pipeline progress, when Cronos (CRON) reports Q4 results.

Cronos (CRON) to Report Q4 Earnings: What's in the Offing?

The ETFMG Alternative Harvest ETF (NYSE: MJ) rebounded by 3.1% on Friday to around $25, but the find is still way off its February high of near $35. On Friday, DataTrek Research co-founder Jessica Rabe discussed what drove the early 2021 cannabis stock rally and three reasons why it has run out of steam in the past two weeks.

3 Reasons Cannabis Stocks May Be Headed Lower

Cron stock and its cohort have accomplished so much with so little. They are swimming upstream and legalization could give them jets.

Cronos Has Done Well But There's More to Come

U.S. companies are overlooked by many investors. But any state and federal legalization favors them over Canadian rivals, fund managers say.

Cannabis Watch: If you want to get rich with marijuana stocks, you need to know the crucial difference between U.S. and Canadian companies

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

Canadian cannabis stocks have surged in 2021 and a few of them have exhibited irrational exuberance such as Tilray and Sundial. U.S. cannabis stocks continue to trade at a substantial discount despite possessing significantly stronger fundamentals.

Tilray, Sundial May Be In A Bubble But This Group Remains Attractive

News for Cronos Group Stock (CRON)